☰

Sean M. Boyle, Ph.D. - Publications

Affiliations: 
Genetics, Genomics and Bioinformatics University of California, Riverside, Riverside, CA, United States 
Tree Info Grants Similar researchers PubMed Report error

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Abbott C, Bedi N, Zhang SV, Li R, Pyke R, Levy E, Chernock R, Mansour M, Sunwoo JB, Colevas AD, Chen R, Boyle SM. Exome scale liquid biopsy characterization of putative neoantigens and genomic biomarkers pre- and post anti-PD-1 therapy in squamous cell carcinoma of the head and neck. Journal of Clinical Oncology. 38: 6557-6557. DOI: 10.1200/Jco.2020.38.15_Suppl.6557  0.336
2020 Abbott CW, Bedi N, Zhang SV, Li R, Pyke RM, Levy E, Chernock R, Mansour M, Sunwoo JB, Colevas AD, Chen R, Boyle SM. Abstract B18: Exome scale liquid biopsy monitoring of putative neoantigens and genomic biomarkers in patients on anti-PD-1 therapy in squamous cell carcinoma of the head and neck Cancer Immunology Research. 8. DOI: 10.1158/2326-6074.Tumimm19-B18  0.341
2020 Pyke RM, Abbott C, Mellacheruvu D, Zhang SV, Bedi N, Colevas AD, Sunwoo J, West J, Chen R, Boyle SM. Abstract 6678: Sensitive HLA loss of heterozygosity detection reveals allele-specific neoantigen expansion as resistance mechanism to anti-PD-1 therapy Cancer Research. 80: 6678-6678. DOI: 10.1158/1538-7445.Am2020-6678  0.341
2020 Abbott CW, Levy E, Pyke RM, McClory R, Jang S, Chen R, Boyle S. Abstract 4278: A composite neoantigen score is more strongly associated with therapeutic response than tumor mutational burden in a cohort of late-stage anti-PD-1-treated melanoma patients Clinical Trials. 80: 4278-4278. DOI: 10.1158/1538-7445.Am2020-4278  0.328
2020 Zhang SV, Tan M, Northcott JM, Ma S, Nelson CS, Bentley LG, Chinnappa M, Bhave DP, Norton D, Harris J, Boyle SM, West J, Chen R. Abstract 1989: Enhanced whole exome profiling of tumor circulating cell-free DNA enables sensitive assessment of tumor mutations Clinical Trials. 80: 1989-1989. DOI: 10.1158/1538-7445.Am2020-1989  0.376
2020 Power RP, Bartha G, Harris J, Boyle SM, Levy E, Milani P, Tandon P, McNitt P, Lee M, Morra M, Desai S, Salvidar S, Clark MJ, Haudenschild C, Jang S, et al. Abstract 1334: A diagnostic platform for precision cancer therapy enabling composite biomarkers by combining tumor and immune features from an enhanced exome and transcriptome Cancer Research. 80: 1334-1334. DOI: 10.1158/1538-7445.Am2020-1334  0.386
2019 Mellacheruvu D, Phillips N, Bartha G, Harris J, Power R, McClory R, West J, Chen R, Boyle SM. Abstract 4536: Applying immunopeptidomics and machine learning to improve neoantigen prediction for therapeutic and diagnostic use Cancer Research. 79: 4536-4536. DOI: 10.1158/1538-7445.Sabcs18-4536  0.303
2019 Zhang SV, Abbott C, Li R, Levy E, Luo S, Power R, McClory R, West J, Chen R, Boyle SM. Abstract 4695: Development and validation of an accurate exome-scale cfDNA detection platform Cancer Research. 79: 4695-4695. DOI: 10.1158/1538-7445.Am2019-4695  0.358
2019 Power R, Bartha G, Harris J, Boyle SM, Levy E, Milani P, Tandon P, Li R, Chinnappa M, McNitt P, McClory R, Morra M, Saldivar S, Clark M, Haudenschild C, et al. Abstract A051: A comprehensive, highly accurate genomics platform for precision immunotherapy: Simultaneously characterize tumors and the TME from a single FFPE sample Molecular Cancer Therapeutics. 18. DOI: 10.1158/1535-7163.Targ-19-A051  0.39
2018 Wang J, Boyle SM, Lee C, Levy E, Rusan Z, Jang S, Chen R. Abstract 5710: Molecular profiling of anti-PD-1 treated melanoma patients reveals importance of assessing neoantigen burden and tumor escape mechanisms for clinical treatment Cancer Research. 78: 5710-5710. DOI: 10.1158/1538-7445.Am2018-5710  0.314
2018 Alla RK, Li R, Boyle SM, Luo S, McClory R, McCord R, West J, Chen R. Abstract 5385: Supporting neoantigen discovery and monitoring in plasma through analytical validation of a deep Augmented Content Enhanced (ACE) exome Cancer Research. 78: 5385-5385. DOI: 10.1158/1538-7445.Am2018-5385  0.381
2018 Boyle SM, Alla R, Wang R, Levy E, Bartha G, Harris J, McCord R, McClory R, West J, Chen R. Abstract 1292: Methods of improving accuracy of neoantigen identification for therapeutic and diagnostic use in immuno-oncology Cancer Research. 78: 1292-1292. DOI: 10.1158/1538-7445.Am2018-1292  0.322
2017 Boyle SM, Harris J, Bartha G, Alla R, Jongeneel P, Karbelashvili M, Kirk S, Chervitz S, Levy E, Rowell C, Thomas D, McCord R, Luo S, West J, Chen R. Validation of an expanded neoantigen identification platform for therapeutic and diagnostic use in immuno-oncology. Journal of Clinical Oncology. 35: 11589-11589. DOI: 10.1200/Jco.2017.35.15_Suppl.11589  0.349
2017 Boyle SM, Harris J, Bartha G, Alla R, Karbelashvili M, Chervitz S, Montana A, Rowell C, Jonganeel P, Kirk S, McClory R, West J, Chen R. Abstract 554: Accurately identifying neoantigens utilizing both DNA and RNA somatic variants in an enhanced platform Cancer Research. 77: 554-554. DOI: 10.1158/1538-7445.Am2017-554  0.346
2017 Yen JL, Boyle S, Alla R, Harris J, Lefterova M, Chen R. Abstract 546: Supporting neoantigen identification for personalized cancer vaccines trough analytical validation of an augmented content enhanced (ACE) transcriptome Cancer Research. 77: 546-546. DOI: 10.1158/1538-7445.Am2017-546  0.379
2016 Boyle SM, McInally S, Tharadra S, Ray A. Short-term memory trace mediated by termination kinetics of olfactory receptor. Scientific Reports. 6: 19863. PMID 26830661 DOI: 10.1038/Srep19863  0.508
2016 Helman E, Clark MJ, Alla R, Boyle S, Virk S, Luo S, Leng N, Church D, Chen R. Effect of assaying the matched normal on clinical cancer sequencing results. Journal of Clinical Oncology. 34: 11561-11561. DOI: 10.1200/Jco.2016.34.15_Suppl.11561  0.327
2016 Boyle SM, Clark MJ, Alla R, Luo S, Church DM, Helman E, Sripakdeevong P, West J, Chen R. Abstract 533: Accurately identifying expressed somatic variants for neoantigen detection and immuno-oncology Cancer Research. 76: 533-533. DOI: 10.1158/1538-7445.Am2016-533  0.364
2016 Alla R, Luo S, Helman E, Boyle SM, Clark MJ, Scott K, Sripakdeevong P, Karbelashvili M, Church DM, Snyder M, West J, Chen R. Abstract 3616: Fix the fixation: effect of formalin fixation on targeted sequencing, variant calling and gene expression Cancer Research. 76: 3616-3616. DOI: 10.1158/1538-7445.Am2016-3616  0.312
2016 Helman E, Clark MJ, Alla R, Boyle SM, Luo S, Virk S, Church D, Sripakdeevong P, Harris J, karbelashvili M, Haudenschild C, West J, Chen R. Abstract 3169: The benefits and burdens of assaying matched normal tissue when sequencing cancer genomes Cancer Research. 76: 3169-3169. DOI: 10.1158/1538-7445.Am2016-3169  0.367
2015 Clark MJ, Helman E, Boyle S, Luo S, Church D, Harris J, Karbelashvili M, Chervitz S, Sripakdeevong P, Bartha G, Patwardhan AJ, West J, Chen R. The detection of clinically relevant cancer mutations using a high depth, augmented, comprehensive cancer gene panel. Journal of Clinical Oncology. 33: e12547-e12547. DOI: 10.1200/Jco.2015.33.15_Suppl.E12547  0.345
2015 Helman E, Clark MJ, Boyle S, Chen R, Luo S, Haudenschild C, Harris J, Bartha G, Church D, West J. Abstract A2-39: Augmented targeted NGS in cancer diagnostics: Comparing gene panels and whole exome sequencing for accurate detection of driver mutations Cancer Research. 75. DOI: 10.1158/1538-7445.Transcagen-A2-39  0.377
2015 Clark MJ, Boyle SM, Helman E, Luo S, Bartha G, Morra M, Patwardhan A, Haudenschild C, Karbelashvili M, Sripakdeevong P, Harris J, Church D, Chervitz S, West J, Chen R. Abstract 4744: Solving genomic assay trade-offs with an optimized, extended cancer gene panel for research and clinical applications Cancer Research. 75: 4744-4744. DOI: 10.1158/1538-7445.Am2015-4744  0.357
2013 Tauxe GM, MacWilliam D, Boyle SM, Guda T, Ray A. Targeting a dual detector of skin and CO2 to modify mosquito host seeking. Cell. 155: 1365-79. PMID 24315103 DOI: 10.1016/J.Cell.2013.11.013  0.502
2013 Boyle SM, McInally S, Ray A. Expanding the olfactory code by in silico decoding of odor-receptor chemical space. Elife. 2: e01120. PMID 24137542 DOI: 10.7554/Elife.01120  0.514
2013 Kain P, Boyle SM, Tharadra SK, Guda T, Pham C, Dahanukar A, Ray A. Odour receptors and neurons for DEET and new insect repellents. Nature. 502: 507-12. PMID 24089210 DOI: 10.1038/Nature12594  0.607
2013 Boyle SM, McInally S, Ray A. Author response: Expanding the olfactory code by in silico decoding of odor-receptor chemical space Elife. DOI: 10.7554/Elife.01120.015  0.48
Show low-probability matches.